This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Cadila Pharmaceuticals Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Vandana Bharat Patravale: Innovator in Pharmaceutical Compositions
Introduction
Vandana Bharat Patravale is a prominent inventor based in Ahmedabad, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance the bioavailability of key compounds.
Latest Patents
Vandana holds two notable patents. The first patent is for "Pharmaceutical compositions of curcumin," which relates to stable liquid pharmaceutical compositions of curcumin or its pharmaceutically acceptable salts or derivatives. This invention boasts higher curcumin concentration and improved bioavailability without the use of buffers or molecular aggregation inhibitors. The curcumin is presented in a solubilized form, ensuring a stable liquid pharmaceutical composition. The second patent is for "Pharmaceutical composition of taxoids," which describes a stable oral pharmaceutical composition with improved solubility and bioavailability. This composition includes a taxoid, a solubilizer, a stabilizing agent, surfactants, solvents, and oil, with the concentration of taxoid ranging from 0.1 to 10%.
Career Highlights
Vandana is associated with Cadila Pharmaceuticals Limited, where she continues to innovate and contribute to the pharmaceutical industry. Her work focuses on enhancing the effectiveness of pharmaceutical formulations, which can lead to better therapeutic outcomes for patients.
Collaborations
Some of her coworkers include Bakulesh Mafatlal Khamar and Ashish Premkumar Gogia, who collaborate with her on various projects within the company.
Conclusion
Vandana Bharat Patravale is a trailblazer in the pharmaceutical field, with her patents reflecting her commitment to improving drug formulations. Her innovative work has the potential to significantly impact the effectiveness of treatments available in the market.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
